Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Erika Gaspari"'
Autor:
Alicia Broto, Erika Gaspari, Samuel Miravet-Verde, Vitor A. P. Martins dos Santos, Mark Isalan
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
Mycoplasmas are minimal cell model organisms but lack genetic tools. Here the authors provide a robust genetic toolkit for Mycoplasma demonstrating gene circuit engineering applications.
Externí odkaz:
https://doaj.org/article/c48ffcf56ee64f81b6a8d4c02e5ebac5
Autor:
Erika Gaspari, Jasper J. Koehorst, Joachim Frey, Vitor A.P. Martins dos Santos, Maria Suarez‐Diez
Publikováno v:
Microbial Biotechnology, Vol 14, Iss 3, Pp 1201-1211 (2021)
Summary Infection by Mycoplasma pneumoniae has been identified as a preceding factor of Guillain–Barré–Stohl syndrome. The Guillain–Barré–Stohl syndrome is triggered by an immune reaction against the major glycolipids and it has been postul
Externí odkaz:
https://doaj.org/article/a04b577cf7f149299d4481d8821463cd
Autor:
Erika Gaspari, Annika Franke, Diana Robles-Diaz, Robert Zweigerdt, Ingo Roeder, Thomas Zerjatke, Henning Kempf
Publikováno v:
Stem Cell Research, Vol 32, Iss , Pp 1-7 (2018)
With their capability to self-renew and differentiate into derivatives of all three germ layers, human pluripotent stem cells (hPSCs) offer a unique model to study aspects of human development in vitro. Directed differentiation towards mesendodermal
Externí odkaz:
https://doaj.org/article/12a120551cce441da3e8611767bc736c
Mycoplasmas have exceptionally streamlined genomes and are strongly adapted to their many hosts, which provide them with essential nutrients. Owing to their relative genomic simplicity, Mycoplasmas have been used for the development of chassis to dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc09eb53826a19051f3c1b18ed487aac
https://doi.org/10.21203/rs.3.rs-951697/v1
https://doi.org/10.21203/rs.3.rs-951697/v1
Autor:
Erika Gaspari
Mycoplasmas are bacteria belonging to the Mollicutes class. They infect a wide range of organisms, among which humans, farm animals, herd animals and pets. Infections by mycoplasmas are currently treated with antibiotics, although many are ineffectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470765b30d9ba1fd09102eaf9a77758f
https://research.wur.nl/en/publications/model-driven-design-of-mycoplasma-as-a-vaccine-chassis
https://research.wur.nl/en/publications/model-driven-design-of-mycoplasma-as-a-vaccine-chassis
Autor:
Erika Gaspari, Luis Garcia-Morales, Luis Serrano, Maria Suarez-Diez, Antoni Malachowski, Vitor A. P. Martins dos Santos, Raul Burgos
Publikováno v:
npj Systems Biology and Applications
npj Systems Biology and Applications, 2020, 6 (1), pp.33. ⟨10.1038/s41540-020-00153-7⟩
npj Systems Biology and Applications, Nature Research, 2020, 6 (1), pp.33. ⟨10.1038/s41540-020-00153-7⟩
npj Systems Biology and Applications, Vol 6, Iss 1, Pp 1-11 (2020)
npj Systems Biology and Applications 6 (2020)
NPJ Systems Biology and Applications
npj Systems Biology and Applications, 6
npj Systems Biology and Applications, 2020, 6 (1), pp.33. ⟨10.1038/s41540-020-00153-7⟩
npj Systems Biology and Applications, Nature Research, 2020, 6 (1), pp.33. ⟨10.1038/s41540-020-00153-7⟩
npj Systems Biology and Applications, Vol 6, Iss 1, Pp 1-11 (2020)
npj Systems Biology and Applications 6 (2020)
NPJ Systems Biology and Applications
npj Systems Biology and Applications, 6
Mycoplasma pneumoniaeis a slow-growing, human pathogen that causes atypical pneumonia. Because it lacks a cell wall, many antibiotics are ineffective, and vaccination is required. Due to its reduced genome and dearth of many biosynthetic pathways, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0006f9f8ed7144ece2159388ab5a475e
http://hdl.handle.net/10230/45770
http://hdl.handle.net/10230/45770